Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres

被引:133
作者
Freytag, T
Dashevsky, A
Tillman, L
Hardee, GE
Bodmeier, R
机构
[1] Free Univ Berlin, Coll Pharm, D-12169 Berlin, Germany
[2] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
oligonucleotide; microencapsulation; microparticles; solvent evaporation method;
D O I
10.1016/S0168-3659(00)00299-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The objective of this study was to encapsulate an oligonucleotide drug within poly(lactide) microparticles with high encapsulation efficiencies at high theoretical drug loadings by the solvent evaporation method. With the conventional W/O/W method, the encapsulation efficiency decreased with increasing internal water content, increasing stirring time prior to filtration of the microparticles and increasing drug loading. The encapsulation was improved by replacing methylene chloride with ethyl acetate, by using micronized drug powder instead of an internal aqueous phase or by adding electrolytes or nonelectrolytes to the external phase. With ethyl acetate, a pre-emulsification step into a smaller volume of external aqueous phase was necessary in order to avoid premature polymer precipitation and to obtain microparticles. The addition of salts (NaCl or MgCl(2)) or sorbitol to the external aqueous phase significantly improved the encapsulation efficiency, even at high theoretical drug loadings. The microparticles had a denser structure with a smooth, pore-free surface. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:197 / 207
页数:11
相关论文
共 26 条
[1]   Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres [J].
Akhtar, S ;
Lewis, KJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 151 (01) :57-67
[2]   ENCAPSULATION OF WATER-SOLUBLE DRUGS BY A MODIFIED SOLVENT EVAPORATION METHOD .1. EFFECT OF PROCESS AND FORMULATION VARIABLES ON DRUG ENTRAPMENT [J].
ALEX, R ;
BODMEIER, R .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :347-355
[3]  
Altmann KH, 1996, CHIMIA, V50, P168
[4]   SOLVENT SELECTION IN THE PREPARATION OF POLY(DL-LACTIDE) MICROSPHERES PREPARED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (1-2) :179-186
[5]   PSEUDOEPHEDRINE HCL MICROSPHERES FORMULATED INTO AN ORAL SUSPENSION DOSAGE FORM [J].
BODMEIER, R ;
CHEN, H ;
TYLE, P ;
JAROSZ, P .
JOURNAL OF CONTROLLED RELEASE, 1991, 15 (01) :65-77
[6]  
Bodmeier R, 1997, Pharm Dev Technol, V2, P323, DOI 10.3109/10837459709022631
[7]   POLYALKYLCYANOACRYLATE NANOPARTICLES AS POLYMERIC CARRIERS FOR ANTISENSE OLIGONUCLEOTIDES [J].
CHAVANY, C ;
LEDOAN, T ;
COUVREUR, P ;
PUISIEUX, F ;
HELENE, C .
PHARMACEUTICAL RESEARCH, 1992, 9 (04) :441-449
[8]  
Cleek RL, 1997, J BIOMED MATER RES, V35, P525, DOI 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO
[9]  
2-A
[10]  
CROTTS G, 1995, P INT S CONTROLLED R, V22, P81